PETMED EXPRESS, INC. financials

PETS CIK 0001040130

Source: EDGAR filings · Built 2026-06-04T02:29:13Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow -33.01M -395.00K -194.00K 22.54M 16.75M 37.64M
EBITDA -49.29M 5.51M -1.11M 9.60M 27.03M 32.96M
Working Capital -8.47M 16.10M 21.49M 72.92M 94.75M 116.25M
Net Debt -20.88M -53.72M -53.84M -104.09M
Gross Margin 28.05% 30.46% 30.93% 30.90% 28.26% 27.77%
Operating Margin -32.77% -0.67% -2.98% 2.44% 8.92% 10.06%
Net Margin -32.00% -2.76% -2.72% 2.08% 6.87% 7.88%
Return on Equity (ROE) -197.95% -7.37% -7.72% 4.67% 15.16% 19.15%
Return on Assets (ROA) -70.56% -4.22% -4.39% 3.07% 10.42% 12.76%
Current Ratio 0.84× 1.26× 1.30× 2.27× 2.68× 3.59×
Debt-to-Equity 0.02× 0.01× 0.01× 0.00×
Effective Tax Rate 0.13% -968.31% -18.99% 30.96% 22.61% 22.72%
Cash Conversion Ratio 0.50× -0.75× -0.58× 5.41× 0.99× 1.68×
Accruals Ratio -0.36× -0.07× -0.07× -0.14× 0.00× -0.09×
SBC % of Revenue 0.76% -2.90% 2.51% 2.67% 1.67% 1.09%
CapEx Coverage -6.15× 0.92× 0.96× 5.29× 10.56× 16.48×
Free Cash Flow Per Share $-1.58 $-0.02 $-0.01 $1.11 $0.82 $1.87

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/E Trailing (Diluted) 64.96× 28.04× 29.55×
P/FCF 14.65× 31.36× 18.80×
FCF Yield 6.83% 3.19% 5.32%
EV / EBITDA 5.96× 24.83× 15.92× 18.03×
P/S 0.27× 0.38× 0.37× 1.38× 1.99× 2.35×
P/B 1.68× 1.02× 1.05× 3.11× 4.38× 5.71×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 179.02M 226.97M 274.10M 247.57M
Cost of Goods and Services Sold 157.84M 189.33M 171.07M 195.34M 219.27M
Gross Profit 50.22M 69.14M 84.77M 76.50M 76.94M 84.32M
Operating Expenses 108.89M 70.67M 92.93M 70.45M 52.65M 53.78M
Operating Income (Loss) -58.67M -1.53M -8.16M 6.05M 24.29M 30.53M
Income Tax Expense (Benefit) -73.00K 5.68M 1.19M 2.31M 5.47M 7.03M
Net Income (Loss) Attributable to Parent -57.29M -6.27M -7.46M 5.14M 18.72M 23.92M
Earnings Per Share, Basic $-2.74 $-0.30 $-0.37 $0.25 $0.93 $1.19
Weighted Average Number of Shares Outstanding, Basic 20.92M 20.60M 20.40M 20.27M 20.18M 20.06M
Earnings Per Share, Diluted $-2.74 $-0.30 $-0.37 $0.25 $0.92 $1.19
Weighted Average Number of Shares Outstanding, Diluted 20.92M 20.60M 20.40M 20.34M 20.36M 20.12M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 21.41M 54.72M 55.30M 104.09M 111.08M 118.72M
Assets, Current 43.56M 78.87M 93.65M 130.43M 151.00M 161.19M
Assets 81.19M 148.70M 169.88M 167.48M 179.70M 187.50M
Liabilities, Current 52.03M 62.77M 72.16M 57.51M 56.25M 44.94M
Liabilities 52.25M 63.57M 73.15M 57.51M 56.25M 46.22M
Stockholders' Equity Attributable to Parent 28.94M 85.13M 96.73M 109.97M 123.45M 124.93M
Common Stock, Shares, Outstanding 21.39M 20.66M 21.15M 21.08M 20.98M 20.27M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -28.39M 4.72M 4.32M 27.80M 18.50M 40.08M
Payments to Acquire Property, Plant, and Equipment 4.62M 5.11M 4.51M 5.26M 1.75M 2.43M
Net Cash Provided by (Used in) Investing Activities -4.62M -5.11M -40.67M -10.26M -1.75M -2.43M
Payments for Repurchase of Common Stock 0 0
Net Cash Provided by (Used in) Financing Activities -299.00K -181.00K -12.44M -24.54M -24.38M -22.69M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PETS CIK 0001040130), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MDGL

MADRIGAL PHARMACEUTICALS, INC.

TRV

Travelers Companies, Inc.

CRS

CARPENTER TECHNOLOGY CORPORATION